Inhibition of pre-protein convertase serine kexin-9 (PCSK-9) as a treatment for hyperlipidaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of pre-protein convertase serine kexin-9 (PCSK-9) as a treatment for hyperlipidaemia

Published:2012-04-12 Issue:5 Volume:21 Page:667-676
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Wierzbicki Anthony S¹,Hardman Timothy C²,Viljoen Adie³

Affiliation:

1. St. Thomas' Hospital Campus, Department of Chemical Pathology, Lambeth Palace Road, London SE1 7EH, UK ; ;

2. Niche Science & Technology, London House, 243-253 Lower Mortlake Road, Richmond-Upon-Thames, London TW9 2LL, UK

3. Lister Hospital, Consultant in Metabolic Medicine/Chemical Pathology, Stevenage, Hertfordshire SG1 4AB, UK

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.679340

Reference94 articles.

1. Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part I

2. Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part II:the early evidence linking hypercholesterolemia to coronary disease in humans

3. Major Lipids, Apolipoproteins, and Risk of Vascular Disease

4. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)

5. The LDL Receptor

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Link between miRNAs and PCKS9 in Atherosclerosis;Current Medicinal Chemistry;2023-11-16

2. Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-09

3. Inhibidores de PCSK-9, efectos sobre el cLDL e implicaciones futuras: lo que se debe saber;Hipertensión y Riesgo Vascular;2017-10

4. Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention;The Annals of Family Medicine;2017-01

5. Diabetic Dyslipidemia and Risk of Cardiovascular Disease;Textbook of Diabetes;2016-12-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3